Diabetic Nephropathies: all 544 studies
Page 6 of 6. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.
- Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 DiabetesCompletedNCT00419484
- Pioglitazone and Losartan Provides Additional RenoprotectionCompletedNCT00364988Not applicable
- Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)CompletedNCT00363987Phase 4
- Olmesartan Medoxomil and Diabetic NephropathyCompletedNCT00362960Phase 3
- Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and NephropathyCompletedNCT00361023Not applicable
- Delaying the Progression of Diabetic Nephropathy in Pima IndiansCompletedNCT00353600
- Family Investigation of Nephropathy and Diabetes (F.I.N.D.)Active, not recruitingNCT00342927
- Angiotensin II Antagonism of TGF-Beta 1CompletedNCT00320970Not applicable
- Effect of Pyridorin in Patients With Diabetic NephropathyCompletedNCT00320060Phase 2
- Effect of Pyridorin in Patients With Diabetic NephropathyCompletedNCT00320021Phase 2
- Spironolactone in Diabetic NephropathyCompletedNCT00317954Phase 4
- Eplerenone, ACE Inhibition and AlbuminuriaCompletedNCT00315016Phase 2
- Study of XL784 in Patients With Albuminuria Due to Diabetic NephropathyCompletedNCT00312780Phase 2
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic NephropathyCompletedNCT00311870Phase 4
- Comprehensive Management of Diabetic Patients With Renal Impairment : Impact on Blood Pressure and Glycemic ControlStatus unknownNCT00306436Not applicable
- The Family Investigation of Nephropathy and Diabetes StudyCompletedNCT00301249
- Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic NephropathyCompletedNCT00295555Phase 4
- 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent AlbuminuriaCompletedNCT00287183Phase 2
- The Use of Cilostazol in Patients With Diabetic NephropathyCompletedNCT00272831Phase 4
- Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic NephropathyCompletedNCT00253786Not applicable
- Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.CompletedNCT00240019Not applicable
- Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic NephropathyCompletedNCT00237952Not applicable
- Enhancing Adherence in Type 2 Diabetes: The ENHANCE StudyCompletedNCT00222846Not applicable
- High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB TherapyCompletedNCT00212901Not applicable
- Antialbuminuric Effects of Valsartan and LisinoprilTerminatedNCT00171600Phase 4
- Antiproteinuric Effect of Valsartan and LisinoprilCompletedNCT00171574Phase 4
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+BenazeprilTerminatedNCT00171119Phase 4
- A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)CompletedNCT00168857Phase 4
- INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic NephropathyCompletedNCT00153088Phase 4
- 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt NephropathyCompletedNCT00153023Phase 4
- European Trial of Immunosuppression in SPK TxCompletedNCT00140543Phase 3
- Nitric Oxide (NO) Activity and Diabetic NephropathyCompletedNCT00136188Phase 2/3
- Effect of Sulodexide in Overt Diabetic NephropathyTerminatedNCT00130312Phase 4
- To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic NephropathyTerminatedNCT00120328Phase 3
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyCompletedNCT00106561Phase 2/3
- Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and ProteinuriaCompletedNCT00097955Phase 2
- Matrix Metalloproteinases and Diabetic NephropathyCompletedNCT00067886
- Soy Protein in Early Diabetic NephropathyCompletedNCT00067678Phase 1/2
- Treatment of Diabetic NephropathyTerminatedNCT00065559Not applicable
- Pirfenidone: A New Drug to Treat Kidney Disease in Patients With DiabetesCompletedNCT00063583Phase 1/2
- The Effect of LY333531 on Protein in the Urine in Patients With Type 2 DiabetesCompletedNCT00044148Phase 2
- The Genetics of Kidneys in Diabetes (GoKinD) StudyCompletedNCT00024921
- Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 DiabetesCompletedNCT00004266Phase 3